Combined immunodeficiency presenting with vaccine- Associated paralytic poliomyelitis: A case report and narrative review of literature

Immunological Investigations

Volumn 43, Issue 3, 2014, Pages 292-298

  Shaghaghi, Mohammadreza ^a   Parvaneh, Nima ^a   Ostad Rahimi, Pouya ^a   Fathi, Seyed Mohammad ^a   Shahmahmoodi, Shohreh ^b   Abolhassani, Hassan ^a   Aghamohammadi, Asghar ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Combined immunodeficiency; Panhypogammaglobulinemia; Poliovirus; Vaccination

Indexed keywords

BCG VACCINE; CEFTAZIDIME; COTRIMOXAZOLE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; ORAL POLIOMYELITIS VACCINE; RAG1 PROTEIN; RAG2 PROTEIN; VANCOMYCIN;

ADVERSE OUTCOME; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; CANDIDIASIS; CASE REPORT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNODEFICIENCY; CHILD; CHRONIC DIARRHEA; COMBINED IMMUNODEFICIENCY; DRUG SAFETY; FECES ANALYSIS; FECES CULTURE; FLACCID PARALYSIS; FLOW CYTOMETRY; HERPES SIMPLEX; HUMAN; IMMUNOPHENOTYPING; LUNG LAVAGE; LYMPHOCYTE TRANSFORMATION TEST; LYMPHOCYTOPENIA; MALE; MUTATIONAL ANALYSIS; PARALYSIS; PARAPLEGIA; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PNEUMOCYSTOSIS; POLIOMYELITIS; POOR GENERAL CONDITION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SALMONELLOSIS; THORAX RADIOGRAPHY; VACCINATION; VACCINE ASSOCIATED PARALYTIC POLIOMYELITIS; X LINKED AGAMMAGLOBULINEMIA;

DNA, VIRAL; HUMANS; INFANT; IRAN; LYMPHOCYTE COUNT; MALE; PARESIS; PERONEAL NERVE; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; RISK; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES; VACCINATION;

EID: 84896273333     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2013.859156     Document Type: Article

References (25)

1. Abo W, Chiba S, Yamanaka T, et al. (1979). Paralytic poliomyelitis in a child with agammaglobulinemia. Euro J Pediatr, 132, 11-6.
2. Alexander JP, Ehresmann K, Seward J, et al. (2009). Transmission of imported vaccinederived poliovirus in an undervaccinated community in Minnesota. J Infect Dis, 199, 391-7.
3. Burns CC, Shaw J, Jorba J, et al. (2013). Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol, 87, 4907-22.
4. Center for Disease Control and Prevention (CDC). (2003). Progress toward poliomyelitis eradication-Ethiopia, Somalia, and Sudan, January 2001-October 2002. JAMA, 289, 1095-7.
5. Center for Disease Control and Prevention (CDC). (2006). Update on vaccine-derived polioviruses. MMWR, 55, 1093-7.
6. Center for Disease Control and Prevention (CDC). (2007). Update on vaccine-derived polioviruses-worldwide, January 2006-August 2007. MMWR, 56, 996-1001.
7. Center for Disease Control and Prevention (CDC). (2011). Update on vaccine-derived polioviruses-worldwide, July 2009-March 2011. MMWR, 60, 846-50.
8. Center for Disease Control and Prevention (CDC). (2012a). Update on vaccine-derived polioviruses-worldwide, April 2011-June 2012. MMWR 61 741-6
9. Center for Disease Control and Prevention (CDC). (2012b). Progress toward interruption of wild poliovirus transmission-worldwide, January 2011-March 2012. MMWR 61 353-7
10. Dashti-Khavidaki S, Aghamohammadi A, Farshadi F, et al. (2009). Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases. J Investig Allergol Clin Immunol, 19, 139-45.
11. Davis LE, Bodian D, Price D, et al. (1977). Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. New Engl J Med, 297, 241-5.
12. Devries AS, Harper J, Murray A, et al. (2011). Vaccine-derived poliomyelitis 12 years after infection in Minnesota. N Engl J Med, 364, 2316-23.
13. Dowdle WR, De Gourville E, Kew OM, et al. (2003). Polio eradication: The OPV paradox. Rev Med Virol, 13, 277-91.
14. Guillot S, Caro V, Cuervo N, et al. (2000). Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol, 74, 8434-43.
15. Henry JL, Jaikaran ES, Davies JR, et al. (1966). A study of poliovaccination in infancy: Excretion following challenge with live virus by children given killed or living poliovaccine. J Hyg, 64, 105-20.
16. Kew OM, Sutter RW, De Gourville EM, et al. (2005). Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Ann Rev Microbiol, 59, 587-635.
17. Khetsuriani N, Prevots DR, Quick L, et al. (2003). Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine- Associated paralytic poliomyelitis. J Infect Dis, 188, 1845-52.
18. Mamishi S, Shahmahmoudi S, Tabatabaie H, et al. (2008). Novel BTK mutation presenting with vaccine- Associated paralytic poliomyelitis. Eur J Pediatr, 167, 1335-8.
19. Murdin AD, Barreto L, Plotkin S. (1996). Inactivated poliovirus vaccine: Past and present experience. Vaccine, 14, 735-46.
20. Parvaneh N, Shahmahmoudi S, Tabatabai H, et al. (2007). Vaccine- Associated paralytic poliomyelitis in a patient with MHC class II deficiency. J Clin Virol: Pan Amer Soc Clin Virol, 39, 145-8.
21. Rosen FS, Cooper MD, Wedgwood RJ. (1995). The primary immunodeficiencies. New Engl J Med, 333, 431-40.
22. Sasaki A, Haraguchi Y, Yoshida H. (2012). Estimating the risk of re-emergence after stopping polio vaccination. Front Microbiol, 3, 1-13.
23. Shahmahmoodi S, Mamishi S, Aghamohammadi A, et al. (2010). Vaccine- Associated paralytic poliomyelitis in immunodeficient children, Iran, 1995-2008. Emerg Infect Dis, 16, 1133-6.
24. Wright PF, Hatch MH, Kasselberg AG, et al. (1977). Vaccine- Associated poliomyelitis in a child with sex-linked agammaglobulinemia. J Pediatr, 91, 408-12.
25. World Health Organization (1997). manual for the virological investigation of polio. WHO/EPI/GEN/97.01.